NOS3 rs3918188C>A is associated with susceptibility to resistant hypertension while CES1 genetic variation was not associated with resistant hypertension among South Africans
IntroductionGenetic variation in genes coding for enzymes metabolising antihypertensive drugs, may affect the efficacy of angiotensin converting enzyme (ACE) inhibitors such as enalapril, potentially leading to resistant hypertension (RHTN). We set out to evaluate the contribution of genetic variati...
Saved in:
| Main Authors: | Jonathan N. Katsukunya, Revina Naicker, Nyarai D. Soko, Dirk Blom, Phumla Sinxadi, Emile R. Chimusa, Brian Rayner, Erika Jones, Collet Dandara |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Genetics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2025.1608423/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenomics of Hypertension in Africa: Paving the Way for a Pharmacogenetic-Based Approach for the Treatment of Hypertension in Africans
by: Jonathan N. Katsukunya, et al.
Published: (2023-01-01) -
Combination therapy in hypertension
by: Brian Rayner
Published: (2007-03-01) -
Pharmacokinetics, pharmacogenetics, and toxicity of co-administered efavirenz and isoniazid
by: Jessica Taylor, et al.
Published: (2025-03-01) -
The young hypertensive
by: B. Rayner
Published: (2012-04-01) -
RETRACTED: An overview of the current state of the beaver’s environmental activity
by: Nazarov Nail, et al.
Published: (2024-01-01)